Lisa Burnapp (ppt, 745kb, opens in new window)
Transcript of Lisa Burnapp (ppt, 745kb, opens in new window)
![Page 1: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/1.jpg)
INCOMPATIBLE LIVING DONOR KIDNEY TRANSPLANTATION
What Choices?
Lisa BurnappConsultant Nurse
Directorate of Nephrology, Transplantation and Urology Guy’s and St Thomas’ NHS Foundation Trust
London, [email protected]
![Page 2: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/2.jpg)
Our Responsibility
To optimise• Patient outcome• Transplant outcome• Planning• Opportunity & choice• Use of kidneys• Donor safety & well-being• The health economy
![Page 3: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/3.jpg)
The Challenge
More
• Patients
• Choice & capability
• Expectation
• Complex
• Ethnically diverse
![Page 4: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/4.jpg)
New Trends in Living Donor Transplantation
![Page 5: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/5.jpg)
Extended Criteria (High-Risk) Recipients
‘Recipients at a significantly higher risk ofdeath, complications or graft failure becauseof pre-existing co-morbidity orimmunological status’1
High-risk includes– Immunological/ABO incompatibility– The elderly– Significant co-morbidity– Primary disease 1 Guidelines for Living Donor Kidney Transplantation in High-
Risk Adult Recipients, 2008 www.bts.org.uk
![Page 6: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/6.jpg)
High-Risk Recipients: Our Approach
• Living donation treatment of choice• All patients provided with information early • Evidence and/or lack of evidence shared with
recipient and donor• Risk benefit analysis discussed• Tailored management plan agreed • Peer support
![Page 7: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/7.jpg)
Who Makes the Choice?
• Patient & family?– What is best for them
• Healthcare professionals?– Most clinically effective– Outcome reporting– What is feasible/available– Local logistics/infrastructure– Financial constraints
• Primary care Trusts/Commissioners?– Health economics– National Guidance (NICE)
![Page 8: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/8.jpg)
Incompatible Living Kidney Donation
![Page 9: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/9.jpg)
Tailored Option Appraisal
• Do nothing– Acceptable if recipient & donor informed of possible options
• Paired/pooled donation
• Antibody removal strategies (ABO/HLA)
• Offer neither– Lack of equity
![Page 10: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/10.jpg)
Paired/Pooled Donation
• Compatible living donor transplant• Clinically more straightforward• Logistically challenging • Uncertainty about timing & ‘matchability’• Donors & recipients unknown to one another
– indirect donation
![Page 11: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/11.jpg)
Antibody Removal Strategies (ABO/HLA)
• More complex scenarios• ^ intervention (recipient)• ^ immunosuppression• Higher risk of failure
– spectrum of risk
• Time specific• Donor known to recipient
– direct donation
![Page 12: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/12.jpg)
![Page 13: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/13.jpg)
Summary
• Evolving field• Clinically challenging• Physically & psychologically demanding for
patients & their families• Compatible transplantation always the
preferred option• Outcomes encouraging
![Page 14: Lisa Burnapp (ppt, 745kb, opens in new window)](https://reader036.fdocuments.us/reader036/viewer/2022062707/5582147cd8b42ac7728b4b01/html5/thumbnails/14.jpg)
Thank you